• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Xeloda (capecitabine) (11/28/2000)

Important safety-related changes to the prescribing information concerning the use of Xeloda in patients with renal impairment at baseline.

[November 28, 2000 - Letter - Roche Pharmaceuticals]
[November 28, 2000 - Package Insert - Roche Pharmaceuticals]